SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

The Cardano-based meme token CockCardano is generating significant buzz as its community leverages real-world business integration through their "Cocky Wings" food venture to fuel token buybacks. Supporters are actively rallying around the project's unique brand identity and ongoing ecosystem expansion, maintaining high engagement across social channels.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

ShapeShift FOX Token is attracting significant community interest as investors weigh its potential for massive growth, often comparing its utility to established DEX platforms like Uniswap. While some participants express frustration over its recent price action and volume, many long-term holders are aggressively accumulating, citing an undervalued market cap and the anticipation of a broader altcoin season.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is capturing significant community attention as investors debate its potential as a high-throughput blockchain solution for institutional finance, often drawing comparisons to XRP and Solana. While bulls are actively accumulating during current volatility, citing high transaction speeds and institutional backing, skeptics remain wary of the project's long-term utility and recent price depreciation.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor Corp. is trending as investors monitor its critical role in power delivery for AI data centers and ongoing patent litigation that could impact its competitive position. The community is actively debating the stock's valuation, recent technical chart patterns, and the potential impact of its technology partnerships on future earnings.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile US is attracting significant market attention as traders closely monitor technical indicators and institutional sentiment ahead of upcoming earnings. While some investors are highlighting the stock's potential for a technical bounce from oversold levels, others are actively debating the impact of sector-wide competition and broader macro pressures on the company's growth trajectory.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is a central focus for traders acting as a macro barometer, with community discussion currently divided between those looking for dip-buying opportunities at key technical support levels and others rotating into defensive sectors like energy and financials. Investors are heavily debating the sustainability of AI capital expenditures versus valuation concerns, as the ETF's price action continues to dictate broader market sentiment amid ongoing rotation away from concentrated mega-cap tech holdings.

ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

T-Rex 2X Long MSTR Daily Target ETF

MSTU is seeing heavy retail engagement as traders weigh aggressive accumulation strategies against concerns over potential reverse stock splits and volatility decay common in leveraged crypto-linked ETFs. The community remains deeply divided, with some betting on a rapid short squeeze driven by Michael Saylor's continued Bitcoin acquisitions, while others warn of significant downside risks if the underlying asset fails to sustain key technical support levels.

Pippin is an SVG unicorn drawn using the latest LLM benchmarks on ChatGPT 4o. It is an autonomous AI agent on X. Pippin was created by Yohei Nakajima, a recognised innovator and thought leader in the Al VC space (followed by Jeff Bezos and Marc Andreessen). He is known for his build-in-public approach and has been at the forefront of the ‘AI for VC’ movement, launching over 100+ AI-driven prototypes, automation agents &amp; open-source projects.  His most notable build is BabyAGI (March 2023), the first popular open-source autonomous agent with task-planning capability. The project went viral on Twitter amassing millions of impressions and resulting in tens of thousands of GitHub stars, dozens of Arxiv citations, coverage across major online media publications globally, and many speaker engagements including the inaugural TED AI in San Francisco.

pippin

PIPPIN is driving intense community debate as traders weigh potential short-squeeze opportunities against heavy warnings regarding high wallet concentration and allegations of market manipulation. While some participants highlight its resilience and momentum as a standout Solana-based AI token, others caution against participating in what they describe as a high-risk asset prone to volatility and insider influence.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors FANG+ Index -3X Inverse Leveraged ETNs

FNGD is currently trending as traders weigh the risks of high valuation in mega-cap technology stocks against potential market rotation and geopolitical instability. The community is actively debating the viability of holding 3X inverse leveraged instruments for hedging purposes, while many express frustration with the technical structure of the ETN and its susceptibility to reverse splits.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is trending as investors react to a mix of analyst optimism and volatility, with major firms maintaining Buy ratings and elevated price targets driven by the potential of its lead asset, Duravyu, in wet AMD and DME. Despite positive institutional sentiment and high ownership, the stock faces pressure from active short interest and ongoing investor debates regarding its competitive position against peers in the ophthalmic TKI space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have...

Is Editas Medicine Going to $0?

Key PointsEditas Medicine has been on fire over the trailing-12-month period...

Editas Medicine Details In Vivo CRISPR Plan, Targets Year-End Human Proof-of-Concept for EDIT-401

Editas Medicine (NASDAQ:EDIT) executives outlined the company's in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore...

Editas Medicine (NASDAQ:EDIT) Upgraded at JonesTrading

JonesTrading raised shares of Editas Medicine from a "hold" rating to a "buy" rating and set a $8.00 price objective on the stock in a research note on Tuesday...

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Editas stock jumps 16% on reporting a narrower-than-expected Q4 loss and beating revenue estimates while advancing its EDIT-401 gene-editing candidate toward its first human study in 2026.

Editas Medicine (NASDAQ:EDIT) Receives "Buy" Rating from Chardan Capital

Chardan Capital reiterated a "buy" rating and issued a $3.50 price target on shares of Editas Medicine in a report on Monday...

Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of +77.78% and +280.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Editas Medicine Q4 Earnings Assessment

Editas Medicine (NASDAQ:EDIT) CEO Sells $10,895.88 in Stock

Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) CEO Gilmore Neil O'neill sold 5,394 shares of Editas Medicine stock in a transaction dated Tuesday, March 3rd. The stock was sold at an average...

Editas Medicine (NASDAQ:EDIT) CEO Gilmore Neil O'neill Sells 5,394 Shares

Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) CEO Gilmore Neil O'neill sold 5,394 shares of the company's stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average...

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

EDIT
Editas Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EDIT News

EDITEditas Medicine Inc